SDZ:SWX
Sandoz Group AG
CHFÂ 82.14
arrow_downward
-0.77%(-0.64) 1D
Nov 4, 5:31:17 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZ...
Open
CHFÂ 82.70
High
CHFÂ 83.04
Low
CHFÂ 81.74
Mkt. cap
36.24B
Avg. vol.
1.22M
Volume
953.43K
Dividend
0.97%
Quarterly dividend
CHFÂ 0.20
Ex-dividend date
Apr 13, 2026
P/E ratio
67.85
52-wk high
CHFÂ 85.62
52-wk low
CHFÂ 52.52
EPS
CHFÂ 1.21
Shares outstanding
440.00M
No. of employees
20K
Open
CHFÂ 82.70
High
CHFÂ 83.04
Low
CHFÂ 81.74
Mkt. cap
36.24B
Avg. vol.
1.22M
Volume
953.43K
Dividend
0.97%
Quarterly dividend
CHFÂ 0.20
Ex-dividend date
Apr 13, 2026
P/E ratio
67.85
52-wk high
CHFÂ 85.62
52-wk low
CHFÂ 52.52
EPS
CHFÂ 1.21
Shares outstanding
440.00M
No. of employees
20K
News stories
From web sources and news partners
Quantisnow
·
4 minutes ago
Blue Owl Technology Finance Corp. Announces September 30, 2026 Financial Results
Virginia Business
·
39 minutes ago
Accendra Health could be delisted by NYSE
The Killeen Daily Herald
·
15 minutes ago
US stocks surge, and the Dow soars more than 1,500 points as oil prices tumble following US midterms
The Washington Post
·
2 hours ago
The S&P 500 climbs after Democrats sweep the midterms
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG
CEORichard Saynor
Employees20K
Founded1886
Headquarters-
SectorPharmaceutical industry
Industry-
Websitesandoz.com